RapidAI, a health tech company specializing in stroke imaging, recently announced it now serves over 50 hospitals and teleradiology services in Australia. Rapid is the first AI-powered stroke imaging solution approved in the country.

The solution is being rolled out across the state of New South Wales (NSW) where it is part of a comprehensive telehealth initiative which leverages the Rapid Mobile App to optimize workflow, communication, and expedite patient treatment throughout the state’s large comprehensive and regional community hospitals.

The company also said it is developing industry leading cerebrovascular imaging solutions through participation in clinical trials with 8 leading Australian hospitals and institutions.

THE LARGER TREND

In September 2020, RapidAI announced a US$25 million Series B round headed by Lennertz & Co and the company said the raise would help advance its platform. RapidAI received clearance from the FDA in the USA for its Rapid ASPECTS neuroimaging analysis device in July 2020, MobiHealthNews reported.

ON THE RECORD

“It has been gratifying to bring RapidAI technology home to support Australian healthcare,” said Dr Roland Bammer, Professor of Radiology and Director of the NHMRC Centre for Research Excellence in Neuroimaging at the University of Melbourne, Cofounder and CTO at RapidAI.

“The statewide adoption in NSW alone has shown the true potential of network coordinated AI-powered stroke imaging and the resulting improvement in care. I am also excited that Monash Health, one of the largest hospital systems in Victoria, is now using Rapid. With its catchment area in the South Eastern Melbourne Metropolitan corridor, the institution reaches over two million Victorians. Access to the Rapid platform will have a considerable positive impact on the Acute Stroke care continuum for the Monash team and its patients,” added Dr Bammer.